Clinical Trial Update: Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

View source ↗

Summary

AstraZeneca-sponsored epidemiology study in postmenopausal women with estrogen receptor-positive breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Hormon Receptor Positive Breast Cancer | Status: COMPLETED